Page 234 - 2021_03-Haematologica-web

880
Letters to the Editor
tiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores. Haematologica. 2016;101(9):1110-1119.
13.Engelhardt M, Domm A-S, Dold SM, et al. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients. Haematologica. 2017;102(5):910-921.
14. Kleber M, Ihorst G, Terhorst M, et al. Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM–comorbidity score. Blood. Cancer J. 2011;1(9):e35.
15. Kleber M, Ihorst G, Udi J, Koch B, Wäsch R, Engelhardt M. Prognostic risk factor evaluation in patients with relapsed or refrac- tory multiple myeloma receiving lenalidomide treatment: analysis of renal function by eGFR and of additional comorbidities by comorbidity appraisal. Clin Lymphoma Myeloma Leuk. 2012;12(1):38-48.
16.Mellqvist U-H. New prognostic tools for myeloma. Blood.
2015;125(13):2014-2015.
17. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evi-
dence for a phenotype. J Gerontol A Biol Sci Med Sci
2001;56(3):M146-156.
18. Greil C, Engelhardt M, Ihorst G, et al. Allogeneic transplantation of
multiple myeloma patients may allow long-term survival in careful- ly selected patients with acceptable toxicity and preserved quality of life. Haematologica. 2019;104(2):370-379.
19. Waldschmidt JM, Keller A, Ihorst G, et al. Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma). Haematologica. 2018;103(10):e473-e479.
20. Larocca A, Palumbo A. How I treat fragile myeloma patients. Blood. 2015;126(19):2179-2185.
21. Zweegman S, Engelhardt M, Larocca A, EHA SWG on ‘Aging and Hematology.’ Elderly patients with multiple myeloma: towards a frailty approach? Curr Opin Oncol. 2017;29(5):315-321.
haematologica | 2021; 106(3)